Logo image of CO

Global Cord Blood Corporation (CO) Stock Price, Quote, News and Overview

NYSE:CO - New York Stock Exchange, Inc. - KYG393421030 - Common Stock - Currency: USD

2.9876  +0.77 (+34.58%)

Premarket: 2.925 -0.06 (-2.1%)

CO Quote, Performance and Key Statistics

Global Cord Blood Corporation

NYSE:CO (9/23/2022, 8:04:01 PM)

Premarket: 2.925 -0.06 (-2.1%)

2.9876

+0.77 (+34.58%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Services
Statistics
52 Week High5.5
52 Week Low2.03
Market Cap400.08M
Shares133.91M
Float38.40M
Yearly DividendN/A
Dividend YieldN/A
PE5.15
Fwd PEN/A
Earnings (Next)10-11 2022-10-11/amc
IPO11-19 2009-11-19


CO short term performance overview.The bars show the price performance of CO in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 20 -20 30

CO long term performance overview.The bars show the price performance of CO in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30

The current stock price of CO is 2.9876 USD. In the past month the price increased by 34.58%. In the past year, price decreased by -35.19%.

Global Cord Blood Corporation / CO Daily stock chart

CO Competitors/Peers

The largest stocks on the US markets in the "Health Care Services" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
CI THE CIGNA GROUP 10.97 82.08B
CVS CVS HEALTH CORP 11.71 79.88B
LH LABCORP HOLDINGS INC 17.15 20.84B
DGX QUEST DIAGNOSTICS INC 19.1 19.12B
FMS FRESENIUS MEDICAL CARE-ADR 13.74 13.55B
BTSGU BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 148.77 12.18B
DVA DAVITA INC 14.99 11.68B
HIMS HIMS & HERS HEALTH INC 112 10.77B
CHE CHEMED CORP 23.84 8.18B
CRVL CORVEL CORP 25.97 5.57B
OPCH OPTION CARE HEALTH INC 26.89 5.45B
GH GUARDANT HEALTH INC N/A 5.30B

About CO

Company Profile

CO logo image Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. The company employs 1,202 full-time employees The company went IPO on 2009-11-19. The firm and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People's Republic of China. The company provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. The company also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. The firm provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. The company also preserves cord blood units donated by the public; provides matching services on such donated units, and delivers matching units to patients in need of transplants.

Company Info

Global Cord Blood Corporation

48 Fl., Bank Of China Tower

HK

CEO: Ting Zheng

Employees: 1202

Company Website: http://www.globalcordbloodcorp.com/

Phone: 85236058180.0

Global Cord Blood Corporation / CO FAQ

What is the stock price of Global Cord Blood Corporation today?

The current stock price of CO is 2.9876 USD. The price increased by 34.58% in the last trading session.


What is the ticker symbol for Global Cord Blood Corporation stock?

The exchange symbol of Global Cord Blood Corporation is CO and it is listed on the New York Stock Exchange, Inc. exchange.


On which exchange is CO stock listed?

CO stock is listed on the New York Stock Exchange, Inc. exchange.


What is Global Cord Blood Corporation worth?

Global Cord Blood Corporation (CO) has a market capitalization of 400.08M USD. This makes CO a Small Cap stock.


How many employees does Global Cord Blood Corporation have?

Global Cord Blood Corporation (CO) currently has 1202 employees.


What are the support and resistance levels for Global Cord Blood Corporation (CO) stock?

Global Cord Blood Corporation (CO) has a resistance level at 3. Check the full technical report for a detailed analysis of CO support and resistance levels.


Should I buy Global Cord Blood Corporation (CO) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does Global Cord Blood Corporation (CO) stock pay dividends?

CO does not pay a dividend.


When does Global Cord Blood Corporation (CO) report earnings?

Global Cord Blood Corporation (CO) will report earnings on 2022-10-11, after the market close.


What is the Price/Earnings (PE) ratio of Global Cord Blood Corporation (CO)?

The PE ratio for Global Cord Blood Corporation (CO) is 5.15. This is based on the reported non-GAAP earnings per share of 0.58 and the current share price of 2.9876 USD. Check the full fundamental report for a full analysis of the valuation metrics for CO.


CO Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to CO. When comparing the yearly performance of all stocks, CO is a bad performer in the overall market: 68.4% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

CO Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to CO. CO is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CO Financial Highlights

Over the last trailing twelve months CO reported a non-GAAP Earnings per Share(EPS) of 0.58. The EPS decreased by -1.41% compared to the year before.


Industry RankSector Rank
PM (TTM) 40.3%
ROA 5.87%
ROE 10.27%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-18%
Sales Q2Q%-1.69%
EPS 1Y (TTM)-1.41%
Revenue 1Y (TTM)7.21%

CO Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 84% to CO. The Buy consensus is the average rating of analysts ratings from 9 analysts.


Ownership
Inst Owners0.03%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
Analysts
Analysts84.44
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A